PARP1 and Huntington disease: The induction of HMOX1 has been demonstrated in an in vivo model of HD to be protective by reducing lipid oxidation, inducing antioxidants, and ameliorating inflammation [137], suggesting the protective role of UCB as the end product of HMOX1, through the PARP pathway.